Abstract
The 4-oxospiro[benzopyran-2,4'-piperidine] ring system is contained within potent class III antiarrhythmic agents. We highlight how these agents can be chemically transformed into a new class of potent (< 1 nM) and selective (> 25-fold) alpha 1a-receptor subtype adrenergic antagonists.
MeSH terms
-
Adrenergic alpha-1 Receptor Antagonists*
-
Animals
-
Anti-Arrhythmia Agents / chemical synthesis
-
Benzopyrans / pharmacology*
-
Humans
-
Male
-
Piperidines / pharmacology*
-
Prostatic Hyperplasia / drug therapy
-
Rats
-
Spiro Compounds / pharmacology*
Substances
-
Adrenergic alpha-1 Receptor Antagonists
-
Anti-Arrhythmia Agents
-
Benzopyrans
-
Piperidines
-
Spiro Compounds